AKESOgen Revenue and Competitors
Estimated Revenue & Valuation
- AKESOgen's estimated annual revenue is currently $1.6M per year.
- AKESOgen's estimated revenue per employee is $155,000
Employee Data
- AKESOgen has 10 Employees.
- AKESOgen grew their employee count by -17% last year.
AKESOgen's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Clinical Laboratory Scientist | Reveal Email/Phone |
AKESOgen Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.9M | 6 | 0% | N/A | N/A |
#2 | $1.7M | 11 | -8% | N/A | N/A |
#3 | $2.3M | 15 | 50% | N/A | N/A |
#4 | $1.1M | 7 | 0% | N/A | N/A |
#5 | $17.1M | 110 | 5% | $0.07B | N/A |
#6 | $4M | 26 | -7% | N/A | N/A |
#7 | $0.8M | 5 | 0% | N/A | N/A |
#8 | $1.1M | 7 | 17% | N/A | N/A |
#9 | $7.8M | 50 | 2% | N/A | N/A |
#10 | $1.7M | 11 | 10% | N/A | N/A |
What Is AKESOgen?
AKESOgen is a biomarker, genomics and pharmacogenomics CRO company that services the academic, pharmaceutical, biotechnology and agricultural sectors. The company is based in Atlanta, GA, USA. AKESOgen performs biomarker profiling and genomics services (e.g. next generation sequencing and genotyping) utilizing different types of markers (e.g. DNA, mRNA, miRNA, methylation) for the R&D market. AKESOgen establishes and validates biomarkers in the Clinical Trials arena. AKESOgen has expertise in Biobanking.
keywords:Biotechnology,Healthcare,Pharmaceuticals
N/A
Total Funding
10
Number of Employees
$1.6M
Revenue (est)
-17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
AKESOgen News
Investors include Bren Investments, Matthew Holt, Chantell Preston, Grail co-founder Jessica Owens, and AKESOgen co-founders Mark Bouzyk and...
“AKESOgen brings a state-of-the-art CLIA-certified and CAP-accredited laboratory facility that enables RenalytixAI to immediately scale ...
LONDON (Alliance News) - Renalytix AI PLC on Wednesday said it has entered into a partnership agreement with laboratory facility provider ...
NEW YORK, Feb. 13, 2019 /PRNewswire/ -- RenalytixAI (AIM: RENX), a developer of artificial intelligence-enabled diagnostics for kidney ...
Other Companies in Norcross
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.9M | 10 | 0% | N/A |
#2 | $0.9M | 10 | 11% | N/A |
#3 | $0.9M | 10 | N/A | N/A |
#4 | $2.5M | 10 | 0% | N/A |
#5 | $1.9M | 11 | -68% | N/A |